blinatumomab,ponatinib
otsuka,amgen,takeda,astellas,incyte
['blinatumomab', 'ponatinib', ' cam ', 'ph+ all', 'lymphoma']
#ash22 ponatinib and blinatumomab for newly diagnosed ph-positive all: subgroup analysis from the phase ii study n=40 impressive results for a chemo-free regimen &gt;possibly reduce need for hsct (1/2) 
Adult BMT & Cellular Therapy @MountSinaiNYC @TischCancer Founder: https://t.co/LFdHmTq9L3… Passion for #bmt #cart #photography #poetry ????? ??